US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

52.65

-0.2639-0.50%

Volume:3K

Turnover:169.57K

Market Cap:50.02M

PE:- -

High:54.55

Open:54.55

Low:52.65

Close:52.91

52wk High:56.18

52wk Low:22.83

Shares:950.00K

Float Shares:950.00K

Volume Ratio:0.53

T/O Rate:0.33%

Dividend:0.65

Dividend Rate:1.24%

ROE:--

ROA:--

PB:1.13

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Revealed: BBC bid just £900k for £5m Commonwealth Games TV rights

Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP

Latigo Biotherapeutics initiated with a Buy at Goldman Sachs

AbbVie Targets Rare Blood Disorder With New Phase 3 Etentamig Trial Plan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/BBC"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Clinical Trials ETF","latestPrice":52.65,"timestamp":1788361745312,"preClose":52.9139,"halted":0,"volume":3163,"delay":0,"changeRate":-0.004987347369972721,"floatShares":950000,"shares":950000,"eps":0,"marketStatus":"Trading","change":-0.2639,"latestTime":"09-02 11:09:38 EDT","open":54.5499,"high":54.5499,"low":52.65,"amount":169573.813426,"amplitude":0.035905,"askPrice":52.76,"askSize":100,"bidPrice":52.07,"bidSize":500,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":52.9139,"sharesOutstanding":900004,"nav":52.968,"aum":50319973.84,"dividendRate":0.012393,"bidAskSpread":0.002379,"postHourTrading":{"tag":"盘后","latestPrice":52.91,"preClose":52.9139,"latestTime":"19:30 EDT","volume":23,"amount":1218.3912,"timestamp":1788305405716,"change":-0.0039,"changeRate":-0.000074,"amplitude":0},"volumeRatio":0.527997,"impliedVol":0.3659,"impliedVolPercentile":0.8056},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","floatShares":950000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.527997,"shares":950000,"dividePrice":0.6525,"high":54.5499,"amplitude":0.035905,"preClose":52.9139,"low":52.65,"week52Low":22.825,"pbRate":"1.13","week52High":56.18,"institutionHeld":0,"latestPrice":52.65,"committee":0.666667,"eps":0,"divideRate":0.012393,"volume":3163,"delay":0,"ttmEps":0,"open":54.5499,"prevYearClose":38.56,"prevWeekClose":53.2941,"prevMonthClose":53.05,"prevQuarterClose":52.6861,"fiveDayClose":55.15,"twentyDayClose":51.193,"sixtyDayClose":40.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBC\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBC","amount":0.65544,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2024-12-20","symbol":"BBC","amount":0.23947,"announcedDate":"2024-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-27"},{"date":"2023-12-20","symbol":"BBC","amount":0.0823,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","recordDate":"2023-12-29","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-29","value":0.0823,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-27","value":0.23947,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-29","value":0.65544,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBC\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664958418","title":"Revealed: BBC bid just £900k for £5m Commonwealth Games TV rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2664958418","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664958418?lang=en_us&edition=fundamental","pubTime":"2026-09-02 12:00","pubTimestamp":1788321600,"startTime":"0","endTime":"0","summary":"The BBC offered 91 per cent less for the Glasgow Commonwealth Games than they paid for Birmingham in 2022 Commonwealth Games chiefs took flak for agreeing a broadcast deal with TNT Sports that put it behind a paywall for the first time in 72 years – but City AM can reveal the BBC offered less than 1m for the rights.The BBC’s bid of around 900,000 represented a 91 per cent decrease on the 10m the organisation paid for the rights to broadcast the 2022 Commonwealth Games in Birmingham.TNT Sports, owned by Warner Bros Discovery, ended up paying around 5m to become the competition’s official UK partner, showing all the action on its linear TV channel and streaming it on HBO Max. TNT Sports costs between 25.99 and 30.99 per month, while HBO Max is available for 4.99 per month.","market":"nz","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/09/GettyImages-2288636445-1.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/09/GettyImages-2288636445-1.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/revealed-bbc-bid-just-900k-for-5m-commonwealth-games-tv-rights/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/revealed-bbc-bid-just-900k-for-5m-commonwealth-games-tv-rights/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855897","title":"Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855897","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855897?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"– Following productive FDA discussions, Upstream Bio will study 400 mg of verekitug administered every 12 weeks, versus placebo, in severe asthma and CRSwNP with one pivotal Phase 3 trial in each indi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353967/0/en/upstream-bio-announces-pivotal-phase-3-development-plans-for-verekitug-in-both-severe-asthma-and-crswnp.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLA","09366","TSLP","LABU","TSDD","TSLG","TSLR","CRSH","TSLO","TESL","TSLI","TSYY","ELOL","TSLT","07766","07366","TSLS","09766","TSLY","TESC","TSII","PSIL","TSLZ","BBC","TSL","TSLL","TEST","TSLQ","TSLW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883471","title":"Latigo Biotherapeutics initiated with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883471","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883471?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:30","pubTimestamp":1788251407,"startTime":"0","endTime":"0","summary":"Goldman Sachs initiated coverage of Latigo Biotherapeutics (LTGO) with a Buy rating and $73 price target Latigo is clinical-stage biotechnology com...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/latigo-biotherapeutics-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/latigo-biotherapeutics-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237438978.USD","AGNG","IE0004086264.USD","LU0868494617.USD","LU0942090050.USD","DARP","LU1894683348.USD","LU2896262040.SGD","LU0106831901.USD","LU2471134523.USD","LTGO","LU0345770993.USD","LU2237443382.USD","FWD","LU1668664300.SGD","LU2471134796.USD","IBB","IE00BFXG1179.USD","BK4550","BK4127","RSPH","LU1868836591.USD","BK4552","IEIH","LU1868836914.USD","LU2237443895.HKD","BK4585","LU1868836757.USD","XT","LU0096364046.USD","LU1144417596.USD","SYNB","LNGR","LU0210536198.USD","BBC","BK4007","BK4516","GSX","LU2237443549.SGD","IE00B19Z3B42.SGD","BBP","IE00BSNM7G36.USD","BK4504","LU2237443622.USD","FHLC","IE0002270589.USD","IE0004091025.USD","JDOC","LU1868837136.USD","LU0251131958.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663009747","title":"AbbVie Targets Rare Blood Disorder With New Phase 3 Etentamig Trial Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2663009747","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663009747?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:31","pubTimestamp":1787934678,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) has posted a new Phase 3 trial plan for its drug etentamig in amy...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-rare-blood-disorder-with-new-phase-3-etentamig-trial-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-rare-blood-disorder-with-new-phase-3-etentamig-trial-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4585","RXL","LU2129689431.USD","IE00BLSP4239.USD","SG9999011175.SGD","LU0942090050.USD","IE00BBT3K403.USD","IE00BSNM7G36.USD","LU0868494708.USD","IE000BZT7R73.USD","LU1244550494.USD","ABBV","AGNG","BK4550","IE0004445239.USD","LU2237443465.HKD","PJP","IE0000B7K699.USD","MEDX","PSIL","IYH","LU1074936037.SGD","LU0795875169.SGD","JDOC","LU2089283258.USD","LU1496350171.SGD","TRUH","IE00B42XCP33.USD","FTXH","IE000SO60NU8.SGD","FHLC","BBC","LU1496350502.SGD","GLAM","LU1267930490.SGD","LU1670627923.USD","LU0320765646.SGD","IE0002141913.USD","IE00B2B36J28.USD","IXJ","VHT","LU1989772840.SGD","PPH","LU0985320562.USD","LU1934455194.USD","LU2112291526.USD","LU0029864427.USD","LU0057025933.USD","LU0726765562.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":32,"pageCount":1,"totalSize":128,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BBC\",params:#limit:6,delay:false,,,undefined,":[]}}